Nasdaq:US$15.39 (+0.28) | HKEX:HK$24.42 (+0.22) | AIM:£2.29 (+0.01)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2010-11-30

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)